UiPath (NYSE:PATH) Stock Price Up 2.9%

UiPath Inc. (NYSE:PATH - Get Free Report)'s share price traded up 2.9% during mid-day trading on Tuesday . The company traded as high as $20.47 and last traded at $20.38. 2,110,427 shares were traded during mid-day trading, a decline of 74% from the average session volume of 8,192,458 shares. The stock had previously closed at $19.80.

Wall Street Analyst Weigh In

PATH has been the topic of a number of analyst reports. TD Cowen raised their price objective on shares of UiPath from $25.00 to $28.00 and gave the company an "outperform" rating in a report on Thursday, March 14th. Morgan Stanley boosted their target price on UiPath from $17.00 to $25.00 and gave the stock an "equal weight" rating in a research note on Thursday, March 14th. Truist Financial reiterated a "buy" rating and issued a $32.00 price target on shares of UiPath in a research note on Wednesday, March 20th. Mizuho boosted their price objective on shares of UiPath from $22.00 to $25.00 and gave the stock a "neutral" rating in a research report on Thursday, March 14th. Finally, KeyCorp started coverage on shares of UiPath in a research report on Monday, April 8th. They issued an "overweight" rating and a $27.00 target price on the stock. Nine equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $27.41.

UiPath Price Performance

The company has a market cap of $11.49 billion, a PE ratio of -118.82 and a beta of 1.01. The company has a 50-day moving average price of $21.23 and a two-hundred day moving average price of $21.93.

UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.10. The company had revenue of $405.25 million during the quarter, compared to analyst estimates of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. On average, equities research analysts anticipate that UiPath Inc. will post -0.04 earnings per share for the current year.

Insider Buying and Selling at UiPath

In other news, CFO Ashim Gupta sold 16,000 shares of the stock in a transaction on Friday, March 15th. The stock was sold at an average price of $22.84, for a total value of $365,440.00. Following the completion of the sale, the chief financial officer now owns 87,505 shares in the company, valued at $1,998,614.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In the last 90 days, insiders have sold 96,000 shares of company stock valued at $2,023,440. Company insiders own 22.37% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of PATH. Mark Sheptoff Financial Planning LLC acquired a new stake in UiPath in the 4th quarter worth $25,000. HighMark Wealth Management LLC acquired a new stake in UiPath during the fourth quarter worth about $27,000. ORG Partners LLC increased its stake in UiPath by 875.6% during the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company's stock valued at $27,000 after acquiring an additional 1,112 shares during the period. Cypress Capital Management LLC WY acquired a new position in UiPath in the 4th quarter valued at approximately $29,000. Finally, Fifth Third Bancorp lifted its position in shares of UiPath by 2,005.3% in the 3rd quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company's stock worth $34,000 after acquiring an additional 1,905 shares during the period. 62.50% of the stock is currently owned by institutional investors and hedge funds.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.